SHANGPHARMA CORP Accounts Receivable, Credit Loss Expense (Reversal)
SHANGPHARMA CORP reported Accounts Receivable, Credit Loss Expense (Reversal) of $149.78 thousand for the 12-month period ending 2011-12-31, per its 20-F/A filed 2012-05-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2012-05-04
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|
| 2011-12-31 | $149.78K 20-F/A · filed 2012-05-04 |
| 2010-12-31 | $34.06K 20-F/A · filed 2012-05-04 |
| 2009-12-31 | $30.00K 20-F/A · filed 2012-05-04 |